FDA Grants Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
The primary outcome was a 90-day incidence of mortality or liver transplant for individuals who received larsucosterol, compared to the placebo group.
Danil Nikonov Jamese Brown Corporation Receives National Library Of Medicine National Library Therapy Designation
Source: pharmacytimes.com